Setting the Benchmark for Efficacy & Safety in CAR-T Therapy

By | 21 April 2026
  • Learnings on dual CAR-T design, why targeting CD20xCD22 simultaneously
  • Rationale for NHL indication
  • Present the eti-cel preliminary data